Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2024 Annual Meeting | S29 - Epilepsy Diagnostics and Therapeutics

Wednesday 04/17/24
01:00 PM - 03:00 PM MDT Add To Calendar
Colorado Convention Center | 605
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Scientific Platform Session
Epilepsy/Clinical Neurophysiology (EEG)
 A group of abstracts covering a similar topic will be presented in an eight-minute oral format followed by four minutes of question and answer with the author. 
2.00 CME credits

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:12 PM MDT Abstract 001 - Physiologically-based Pharmacokinetic Modeling to Predict Drug–drug Interactions of Soticlestat
Lawrence H Cohen
01:12 PM - 01:24 PM MDT Abstract 002 - Seizure Freedom After Failure of Levetiracetam vs. Sodium Channel Blocker
Alexandra Chaves
01:24 PM - 01:36 PM MDT Abstract 003 - Effectiveness of Cenobamate in Reducing Focal Onset Seizure-related Hospitalizations: A Retrospective Claims-based Analysis
Alexandra Urban, MD, FAAN
01:36 PM - 01:48 PM MDT Abstract 004 - Relative Bioavailability of Cenobamate 200 mg Administered as a Crushed Tablet, Either Orally or via Nasogastric Tube, vs. an Intact 200 mg Cenobamate Tablet
Vijaykumar Vashi, PhD
01:48 PM - 02:00 PM MDT Abstract 005 - Long-term Effectiveness of Cannabidiol (CBD) Against Focal-onset Seizures in Treatment-resistant Epilepsies (TRE): Experience from the Expanded Access Program (EAP)
Karthik Rajasekaran, PhD
02:00 PM - 02:12 PM MDT Abstract 006 - Characterization of BHV-7000: A Novel Kv7.2/7.3 Activator for the Treatment of Seizures
Kelly Picchione, PhD
02:12 PM - 02:24 PM MDT Abstract 007 - Investigating the Role of Parvalbumin Interneurons in VNS Efficacy
Kelsey Patterson, MD
02:24 PM - 02:36 PM MDT Abstract 008 - Enhanced Sensitivity of Electrocorticography During Awake Craniotomy Using a Novel Circular Grid Electrode
Brin Freund, MD
02:36 PM - 02:48 PM MDT Abstract 009 - Quantifying the Impact of Computer-aided Diagnostic Score on the Diagnosis of Functional Seizures
Katherine McFarlane, MS
02:48 PM - 03:00 PM MDT Abstract 010 - Toward Meta-connectomic Ergodicity in Neuroimaging: Theoretical and Experimental Motivation for Developing Data-driven Biomarkers
Jonathan Michael Towne
Faculty Disclosures
Rodrigo Zepeda Garcia, MD The institution of Dr. Zepeda Garcia has received research support from NIH.
Katherine A. Riester, MPH No disclosure on file
Jonathan Michael Towne The institution of Mr. Towne has received research support from the American Epilepsy Society (Predoctoral Research Fellowship) and the National Institutes of Health (F31NS131025, T32TR004545, T32GM113896).
Victor Lami, MD Dr. Eslami has nothing to disclose.
Heath Pardoe No disclosure on file
Jose E. Cavazos, MD, PhD Dr. Cavazos has received stock or an ownership interest from Brain Sentinel . The institution of Dr. Cavazos has received research support from NIH.
Peter T. Fox, MD Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. The institution of Dr. Fox has received research support from NIH. Dr. Fox has received intellectual property interests from a discovery or technology relating to health care. Dr. Fox has received personal compensation in the range of $500,000-$999,999 for serving as a Reviewer with NIH.
Marianne T. Sweetser, MD, PhD Dr. Sweetser has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Dr. Sweetser has received stock or an ownership interest from Alnylam Pharmaceuticals.
Janice Laramy, PhD,Other Dr. Laramy has received personal compensation for serving as an employee of SK Life Science, Inc.
Louis Ferrari Louis Ferrari has received personal compensation for serving as an employee of SK Life science.
Marc Kamin, MD Dr. Kamin has received personal compensation for serving as an employee of SK LIFE SCIENCE INC.
Vijaykumar Vashi, PhD Dr. Vashi has received personal compensation for serving as an employee of SK Life Science Inc.
Jacob S. Elkins, MD No disclosure on file
Wei Yin Wei Yin has received personal compensation for serving as an employee of Takeda. Wei Yin has stock in Takeda.
Thomas Ballard, PhD Dr. Ballard has received personal compensation for serving as an employee of Takeda. Dr. Ballard has stock in Takeda.
Liming Zhang, PhD Mr. Zhang has received personal compensation for serving as an employee of Takeda. Mr. Zhang has stock in Takeda.
Lawrence H Cohen Mr. Cohen has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Mr. Cohen has stock in Takeda.
Mackenzie C. Bergagnini-Kolev, PhD Dr. Bergagnini-Kolev has received personal compensation for serving as an employee of Certara UK Limited. Dr. Bergagnini-Kolev has stock in Certara UK Limited.
Hannah Jones, PhD Dr. Jones has stock in Certara.
Hongxia Jia, MD,PhD Dr. Jia has received personal compensation for serving as an employee of Takeda Pharmaceutical Company Limited. Dr. Jia has stock in Takeda Pharmaceutical Company Limited.
Ian E. Templeton, PhD Dr. Templeton has received personal compensation for serving as an employee of Certara. Dr. Templeton has stock in Certara.
Eliahu Heldman, PhD No disclosure on file
Allyson L. Alexander, MD,PhD Dr. Alexander has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NuXcel. The institution of Dr. Alexander has received research support from NIH.
Keenan Keenan Kushner Mr. Kushner has nothing to disclose.
Kelsey Patterson, MD Dr. Patterson has nothing to disclose.
Christine Brzezinski, Other Ms. Brzezinski has nothing to disclose.
Sarina Grinberg No disclosure on file
Alexandra Urban, MD, FAAN Dr. Urban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuropace. Dr. Urban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life Science, Inc.
Sean Stern Mr. Stern has received personal compensation for serving as an employee of SK Life Science.
Clarence Wade Mr. Wade has received personal compensation for serving as an employee of SK Life Science, Inc..
Vernon Francis Schabert, III, PhD Dr. Schabert has nothing to disclose.
Mary Popov No disclosure on file
Alexandra Chaves Miss Chaves has nothing to disclose.
Ojas Potnis Mr. Potnis has nothing to disclose.
John M. Gledhill, Jr., PhD Dr. Gledhill has received personal compensation for serving as an employee of Cognizance Biomarkers. The institution of Dr. Gledhill has received research support from CURE Epilepsy.
Jacqueline French, MD, FAAN Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Epilepsy Foundation. The institution of Dr. French has received research support from Epilepsy Study Consortium/ Epilepsy Foundation (Funded by UCB). The institution of Dr. French has received research support from GW/One8 Foundation/FACES. The institution of Dr. French has received research support from NINDS. The institution of Dr. French has received research support from Xenon. The institution of Dr. French has received research support from Cerevel. The institution of Dr. French has received research support from FACES. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Epilepsy Study Consortium. The institution of Dr. French has received research support from UCB. Dr. French has received personal compensation in the range of $100,000-$499,999 for serving as a Chief Medical/Innovation Officer with Epilepsy Foundation. Dr. French has a non-compensated relationship as a Consultant with Angelini that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Alterity Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Bright minds Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerecin Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cognizance Biomarkers that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Arvelle that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Beacon biosignals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biohaven Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bloom Science Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with BridgeBio Pharma Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant, scientific advisory board with Camp4 Therapeutics Corporation that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Scientific Advisory Board with Cerebral Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerevel that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a SAB with Coda Biotherapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Genentech Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Crossject that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Eisai, that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Eliem Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Encoded Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with iQure Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Engrail that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a SAB with Epihunter that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a SAB with Epiminder that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Epitel Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Equilibre BioPharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Greenwich Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Grin Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with GW Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Janssen Pharmaceutica that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Jazz Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Knopp Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Lipocine that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with LivaNova that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Longboard Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Lundbeck that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Marinus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Modulight Bio that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Leal therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neumirna Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant,SAB with Neurocrine that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neuroelectrics USA Corporation that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neuronetics Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Ono Pharmaceutical Co that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Otsuka Pharmaceutical Development that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Ovid Therapeutics Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Paladin Labs Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Rapport Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Praxis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with PureTech LTY Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with SK Life Sciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Stoke that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Supernus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Takeda that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with UCB Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Ventus Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, steering committee with Xenon that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Korro Bio Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with NeuroPro Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory board with Receptor that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory board with Sage Therpeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with Third Rock Ventures that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Vida Ventures Management that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Pfizer that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Agrithera, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting with Autifony therapeutics, Unlimited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Baergic Bio that is relevant to AAN interests or activities.
Manisha Gupte Holmes, MD Dr. Holmes has nothing to disclose.
Sarah Barnard Sarah Barnard has nothing to disclose.
Wahab Syed Hameed, MD No disclosure on file
Brin Freund, MD Dr. Freund has nothing to disclose.
Anteneh Mekonnen Feyissa, MD, MSc, FAAN Dr. Feyissa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis.
Aafreen Khan, MD Dr. Khan has nothing to disclose.
Joseph I. Sirven, MD, FAAN Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurona. Dr. Sirven has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Sirven has received publishing royalties from a publication relating to health care. Dr. Sirven has a non-compensated relationship as a Host with WJCT Public Media/ NPR that is relevant to AAN interests or activities.
Sanjeet S. Grewal, MD Sanjeet S. Grewal, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic.
David Sabsevitz No disclosure on file
Diogo Garcia, MD Dr. Garcia has nothing to disclose.
Alfredo Quinones-Hinojosa No disclosure on file
William O. Tatum, IV, DO, FAAN Dr. Tatum has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bioserenity. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Defense Law Firm on behalf of a patient with epilepsy with funds donated to the Epilepsy Foundation of America. The institution of Dr. Tatum has received research support from Esai. The institution of Dr. Tatum has received research support from Mayo Clinic. The institution of Dr. Tatum has received research support from Liva Nova. The institution of Dr. Tatum has received research support from Engage Pharmaceuticals. The institution of Dr. Tatum has received research support from Xenon. Dr. Tatum has received intellectual property interests from a discovery or technology relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has a non-compensated relationship as a AAN Section Chair of Clinical Neurophysiology with AAN that is relevant to AAN interests or activities.
Anam Ong No disclosure on file
Kelly Picchione, PhD Dr. Picchione has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Picchione has stock in Biohaven Pharmaceuticals. Dr. Picchione has received intellectual property interests from a discovery or technology relating to health care.
Lynn Resnick, PhD Dr. Resnick has received personal compensation for serving as an employee of Biohaven Pharmceuticals. Dr. Resnick has received personal compensation for serving as an employee of Knopp Biosciences. Dr. Resnick has stock in Biohaven Pharmceuticals. Dr. Resnick has stock in Knopp Biosciences. Dr. Resnick has received intellectual property interests from a discovery or technology relating to health care. Dr. Resnick has received intellectual property interests from a discovery or technology relating to health care.
Michael E. Bozik, MD Dr. Bozik has received personal compensation for serving as an employee of Biohaven . Dr. Bozik has stock in Biohaven.
Steven Dworetzky, PhD Dr. Dworetzky has received personal compensation for serving as an employee of Biohaven. Dr. Dworetzky has stock in Bristol-Myers Squibb. Dr. Dworetzky has received research support from NIH.
Muhammad Karyana No disclosure on file
Katherine McFarlane, MS Ms. McFarlane has nothing to disclose.
Corinne Allas Corinne Allas has nothing to disclose.
Samuel Waller Terman, MD Dr. Terman has received research support from American Epilepsy Society. Dr. Terman has received research support from Epilepsy Study Consortium. Dr. Terman has received research support from New York University. Dr. Terman has received personal compensation in the range of $100,000-$499,999 for serving as a clinician scientist trainee for Susan S Spencer award with American Academy of Neurology.
Sung Hyun Seo, MD Dr. Seo has nothing to disclose.
Amir Karimi Amir Karimi has nothing to disclose.
Siddhika Sreenivasan No disclosure on file
Jena Grauer Jena Grauer has nothing to disclose.
Di Sun, PhD Ms. Sun has nothing to disclose.
Meagan Marie Watson Ms. Watson has nothing to disclose.
Elissa Patterson, PhD Dr. Patterson has nothing to disclose.
John M. Stern, MD, FAAN Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharma. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for LivaNova. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Stern has stock in DEARhealth. Dr. Stern has stock in Ceribell. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care.
Jamie Feusner Dr. Feusner has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for NOCD, Inc.. Dr. Feusner has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Nature Springer (Translational Psychiatry). The institution of Dr. Feusner has received research support from NIH.
Laura A. Strom, MD Dr. Strom has nothing to disclose.
William Stacey, MD No disclosure on file
Wesley Kerr, MD, PhD Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Lifesciences. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EpiTel. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Pharmaceuticals. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerebral Therapeutics. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. The institution of Dr. Kerr has received research support from NINDS. The institution of Dr. Kerr has received research support from American Epilepsy Society. The institution of Dr. Kerr has received research support from American Academy of Neurology. Dr. Kerr has received publishing royalties from a publication relating to health care.
Nilufer Kale, MD Dr. Kale has nothing to disclose.
Yong D. Park, MD, FAAN Dr. Park has nothing to disclose.
Karthik Rajasekaran, PhD Dr. Rajasekaran has received personal compensation for serving as an employee of Jazz Pharmaceuticals.
Teresa Greco, PhD Dr. Greco has received personal compensation for serving as an employee of Jazz Pharmaceuticals.
Farhad Sahebkar-Moghaddam, MD Dr. Sahebkar-Moghaddam has received personal compensation for serving as an employee of Jazz pharmaceuticals. Dr. Sahebkar-Moghaddam has stock in Jazz pharmaceuticals.
Robert Flamini, MD Dr. Flamini has received personal compensation in the range of $0-$499 for serving as a Consultant for Biocodex. Dr. Flamini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Dr. Flamini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals.
Kelsey Marie Smith, MD The institution of Dr. Smith has received research support from CURE Epilepsy. The institution of Dr. Smith has received research support from UCB Pharmaceuticals.